FDA Inspection 1266772 — Implant Direct Sybron Manufacturing LLC
The FDA completed an inspection of Implant Direct Sybron Manufacturing LLC on Apr 2, 2025 in Pomona, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 2, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Pomona, CA (United States)